MyFinsight
Home
Blog
About
Cash and cash
equivalents
$155,098K
(180.42%↑ Y/Y)
Other current assets
and prepaid...
$2,735K
(-39.65%↓ Y/Y)
Total current assets
$157,833K
(163.75%↑ Y/Y)
Property and equipment,
net
$771K
(25.98%↑ Y/Y)
Right-of-use assets
$565K
(-42.05%↓ Y/Y)
Total assets
$159,169K
(159.11%↑ Y/Y)
Total liabilities and
stockholders equity...
$159,169K
(159.11%↑ Y/Y)
Total stockholders
equity (deficit)
$127,581K
(276.22%↑ Y/Y)
Total liabilities
$31,588K
(14.79%↑ Y/Y)
Accumulated deficit
-$675,258K
(-19.79%↓ Y/Y)
Additional paid-in capital
$800,054K
(34.45%↑ Y/Y)
Total current
liabilities
$31,260K
(14.45%↑ Y/Y)
Total long-term
liabilities
$328K
(60.00%↑ Y/Y)
Accumulated other
comprehensive income
$2,772K
(9.78%↑ Y/Y)
Common stock, 0.0001
par value...
$13K
(44.44%↑ Y/Y)
Accrued expenses
$17,852K
(-1.44%↓ Y/Y)
Accounts payable
$12,665K
(60.46%↑ Y/Y)
Other current
liabilities
$743K
(-43.15%↓ Y/Y)
Operating lease
liabilities
$328K
(60.00%↑ Y/Y)
Back
Back
Balance Sheet
IMMUNIC, INC. (IMUX)
IMMUNIC, INC. (IMUX)
source: myfinsight.com